Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach ; day:30 ; month:4 ; year:2024 ; pages:1-5
Leukemia ; (30.4.2024), 1-5
- Urheber
-
Walker, Ieuan G.
Roy, James P.
Anderson, Georgina S. F.
Guerrero Lopez, Jose
Chapman, Michael A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-024-02247-1
- URN
-
urn:nbn:de:101:1-2407122131564.978237047620
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Walker, Ieuan G.
- Roy, James P.
- Anderson, Georgina S. F.
- Guerrero Lopez, Jose
- Chapman, Michael A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacological control of CAR T-cells by dasatinib
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
Digital-droplet PCR for quantification of CD19-directed CAR T-cells
Prospects for combined use of oncolytic viruses and CAR T-cells
CAR-T cells in multiple myeloma: current status
CAR T-cells for pediatric solid tumors: where to go from here?
The essential effector role of T-cells in bacteria-mediated tumor therapy
CAR T therapies in multiple myeloma: unleashing the future
Updates on CAR T cell therapy in multiple myeloma
Deciphering the importance of culture pH on CD22 CAR T-cells characteristics
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
Pharmacological control of CAR T-cells by dasatinib
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
Digital-droplet PCR for quantification of CD19-directed CAR T-cells
Prospects for combined use of oncolytic viruses and CAR T-cells
CAR-T cells in multiple myeloma: current status
CAR T-cells for pediatric solid tumors: where to go from here?
The essential effector role of T-cells in bacteria-mediated tumor therapy
CAR T therapies in multiple myeloma: unleashing the future
Updates on CAR T cell therapy in multiple myeloma
Deciphering the importance of culture pH on CD22 CAR T-cells characteristics
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
Pharmacological control of CAR T-cells by dasatinib
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
Digital-droplet PCR for quantification of CD19-directed CAR T-cells
Prospects for combined use of oncolytic viruses and CAR T-cells
CAR-T cells in multiple myeloma: current status
CAR T-cells for pediatric solid tumors: where to go from here?
The essential effector role of T-cells in bacteria-mediated tumor therapy
CAR T therapies in multiple myeloma: unleashing the future
Updates on CAR T cell therapy in multiple myeloma
Deciphering the importance of culture pH on CD22 CAR T-cells characteristics